Vikhyat S Bebarta1, David A Tanen2, Susan Boudreau3, Maria Castaneda3, Lee A Zarzabal3, Toni Vargas3, Gerry R Boss4. 1. Medical Toxicology, San Antonio Military Medical Center, San Antonio, TX. Electronic address: vikbebarta@yahoo.com. 2. David Geffen School of Medicine at UCLA, Harbor-UCLA Medical Center, Torrance, CA. 3. Department of Emergency Medicine, San Antonio Military Medical Center, San Antonio, TX. 4. University of California, San Diego, San Diego, CA.
Abstract
STUDY OBJECTIVE: Hydroxocobalamin is a Food and Drug Administration-approved antidote for cyanide poisoning. Cobinamide is a potential antidote that contains 2 cyanide-binding sites. To our knowledge, no study has directly compared hydroxocobalamin with cobinamide in a severe, cyanide-toxic large-animal model. Our objective is to compare the time to return of spontaneous breathing in swine with acute cyanide-induced apnea treated with intravenous hydroxocobalamin, intravenous cobinamide, or saline solution (control). METHODS: Thirty-three swine (45 to 55 kg) were intubated, anesthetized, and instrumented (continuous mean arterial pressure and cardiac output monitoring). Anesthesia was adjusted to allow spontaneous breathing with FiO2 of 21% during the experiment. Cyanide was continuously infused intravenously until apnea occurred and lasted for 1 minute (time zero). Animals were then randomly assigned to receive intravenous hydroxocobalamin (65 mg/kg), cobinamide (12.5 mg/kg), or saline solution and monitored for 60 minutes. A sample size of 11 animals per group was selected according to obtaining a power of 80%, an α of .05, and an SD of 0.17 in mean time to detect a 20% difference in time to spontaneous breathing. We assessed differences in time to death among groups, using Kaplan-Meier estimation methods, and compared serum lactate, blood pH, cardiac output, mean arterial pressure, respiratory rate, and minute ventilation time curves with repeated-measures ANOVA. RESULTS: Baseline weights and vital signs were similar among groups. The time to apnea and cyanide dose required to achieve apnea were similar. At time zero, mean cyanide blood and lactate concentrations and reduction in mean arterial pressure from baseline were similar. In the saline solution group, 2 of 11 animals survived compared with 10 of 11 in the hydroxocobalamin and cobinamide groups (P<.001 between the 2 treated groups and the saline solution group). Time to return of spontaneous breathing after antidote was similar between hydroxocobalamin and cobinamide (1 minute 48 seconds versus 1 minute 49 seconds, respectively). Blood cyanide concentrations became undetectable at the end of the study in both antidote-treated groups, and no statistically significant differences were detected between the 2 groups for mean arterial pressure, cardiac output, respiratory rate, lactate, or pH. CONCLUSION: Both hydroxocobalamin and cobinamide rescued severely cyanide-poisoned swine from apnea in the absence of assisted ventilation. The dose of cobinamide was one fifth that of hydroxocobalamin.
STUDY OBJECTIVE:Hydroxocobalamin is a Food and Drug Administration-approved antidote for cyanidepoisoning. Cobinamide is a potential antidote that contains 2 cyanide-binding sites. To our knowledge, no study has directly compared hydroxocobalamin with cobinamide in a severe, cyanide-toxic large-animal model. Our objective is to compare the time to return of spontaneous breathing in swine with acute cyanide-induced apnea treated with intravenous hydroxocobalamin, intravenous cobinamide, or saline solution (control). METHODS: Thirty-three swine (45 to 55 kg) were intubated, anesthetized, and instrumented (continuous mean arterial pressure and cardiac output monitoring). Anesthesia was adjusted to allow spontaneous breathing with FiO2 of 21% during the experiment. Cyanide was continuously infused intravenously until apnea occurred and lasted for 1 minute (time zero). Animals were then randomly assigned to receive intravenous hydroxocobalamin (65 mg/kg), cobinamide (12.5 mg/kg), or saline solution and monitored for 60 minutes. A sample size of 11 animals per group was selected according to obtaining a power of 80%, an α of .05, and an SD of 0.17 in mean time to detect a 20% difference in time to spontaneous breathing. We assessed differences in time to death among groups, using Kaplan-Meier estimation methods, and compared serum lactate, blood pH, cardiac output, mean arterial pressure, respiratory rate, and minute ventilation time curves with repeated-measures ANOVA. RESULTS: Baseline weights and vital signs were similar among groups. The time to apnea and cyanide dose required to achieve apnea were similar. At time zero, mean cyanide blood and lactate concentrations and reduction in mean arterial pressure from baseline were similar. In the saline solution group, 2 of 11 animals survived compared with 10 of 11 in the hydroxocobalamin and cobinamide groups (P<.001 between the 2 treated groups and the saline solution group). Time to return of spontaneous breathing after antidote was similar between hydroxocobalamin and cobinamide (1 minute 48 seconds versus 1 minute 49 seconds, respectively). Blood cyanide concentrations became undetectable at the end of the study in both antidote-treated groups, and no statistically significant differences were detected between the 2 groups for mean arterial pressure, cardiac output, respiratory rate, lactate, or pH. CONCLUSION: Both hydroxocobalamin and cobinamide rescued severely cyanide-poisoned swine from apnea in the absence of assisted ventilation. The dose of cobinamide was one fifth that of hydroxocobalamin.
Authors: Kate E Broderick; Prasanth Potluri; Shunhui Zhuang; Immo E Scheffler; Vijay S Sharma; Renate B Pilz; Gerry R Boss Journal: Exp Biol Med (Maywood) Date: 2006-05
Authors: A H Idris; L B Becker; J P Ornato; J R Hedges; N G Bircher; N C Chandra; R O Cummins; W Dick; U Ebmeyer; H R Halperin; M F Hazinski; R E Kerber; K B Kern; P Safar; P A Steen; M M Swindle; J E Tsitlik; I von Planta; M von Planta; R L Wears; M H Weil Journal: Circulation Date: 1996-11-01 Impact factor: 29.690
Authors: Matthew Brenner; Sari B Mahon; Jangwoen Lee; Jae Kim; David Mukai; Seth Goodman; Kelly A Kreuter; Rebecca Ahdout; Othman Mohammad; Vijay S Sharma; William Blackledge; Gerry R Boss Journal: J Biomed Opt Date: 2010 Jan-Feb Impact factor: 3.170
Authors: Stephen W Borron; Frédéric J Baud; Patrick Barriot; Michel Imbert; Chantal Bismuth Journal: Ann Emerg Med Date: 2007-05-04 Impact factor: 5.721
Authors: Matthew Brenner; Jae G Kim; Sari B Mahon; Jangwoen Lee; Kelly A Kreuter; William Blackledge; David Mukai; Steve Patterson; Othman Mohammad; Vijay S Sharma; Gerry R Boss Journal: Ann Emerg Med Date: 2010-01-04 Impact factor: 5.721
Authors: Kate E Broderick; Maheswari Balasubramanian; Adriano Chan; Prasanth Potluri; Jake Feala; Darrell D Belke; Andrew McCulloch; Vijay S Sharma; Renate B Pilz; Timothy D Bigby; Gerry R Boss Journal: Exp Biol Med (Maywood) Date: 2007-06
Authors: Jangwoen Lee; Sari B Mahon; David Mukai; Tanya Burney; Behdod S Katebian; Adriano Chan; Vikhyat S Bebarta; David Yoon; Gerry R Boss; Matthew Brenner Journal: J Med Toxicol Date: 2016-09-15
Authors: Vikhyat S Bebarta; Matthew Brittain; Adriano Chan; Norma Garrett; David Yoon; Tanya Burney; David Mukai; Michael Babin; Renate B Pilz; Sari B Mahon; Matthew Brenner; Gerry R Boss Journal: Ann Emerg Med Date: 2016-12-29 Impact factor: 5.721
Authors: Elisenda Lopez-Manzano; Andrea A Cronican; Kristin L Frawley; Jim Peterson; Linda L Pearce Journal: Chem Res Toxicol Date: 2016-05-26 Impact factor: 3.739
Authors: Adriano Chan; Jingjing Jiang; Alla Fridman; Ling T Guo; G Diane Shelton; Ming-Tao Liu; Carol Green; Kristofer J Haushalter; Hemal H Patel; Jangwoen Lee; David Yoon; Tanya Burney; David Mukai; Sari B Mahon; Matthew Brenner; Renate B Pilz; Gerry R Boss Journal: J Med Chem Date: 2015-02-16 Impact factor: 7.446
Authors: Christine M Murphy; Cliff Williams; Michael E Quinn; Brian Nicholson; Thomas Shoe; Michael C Beuhler; William P Kerns Journal: J Med Toxicol Date: 2016-08-08
Authors: Tara B Hendry-Hofer; Alyssa E Witeof; Dennean S Lippner; Patrick C Ng; Sari B Mahon; Matthew Brenner; Gary A Rockwood; Vikhyat S Bebarta Journal: Clin Toxicol (Phila) Date: 2018-10-11 Impact factor: 4.467
Authors: Philippe Haouzi; Nicole Tubbs; Matthew D Rannals; Annick Judenherc-Haouzi; Larry A Cabell; Joe A McDonough; Takashi Sonobe Journal: Shock Date: 2017-03 Impact factor: 3.454
Authors: Patrick C Ng; Tara B Hendry-Hofer; Alyssa E Witeof; Matthew Brenner; Sari B Mahon; Gerry R Boss; Vikhyat S Bebarta Journal: Comp Med Date: 2018-09-12 Impact factor: 0.982